VistaGen Therapeutics
VTGN
VTGN
51 hedge funds and large institutions have $30.3M invested in VistaGen Therapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.1% less ownership
Funds ownership: 55.24% → 53.14% (-2.1%)
22% less capital invested
Capital invested by funds: $39M → $30.3M (-$8.74M)
Holders
51
Holding in Top 10
–
Calls
$437K
Puts
$73K
Top Buyers
| 1 | +$190K | |
| 2 | +$101K | |
| 3 | +$88K | |
| 4 |
SC
Stempoint Capital
New York
|
+$79.7K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$69.3K |
Top Sellers
| 1 | -$685K | |
| 2 | -$401K | |
| 3 | -$324K | |
| 4 |
Morgan Stanley
New York
|
-$78.3K |
| 5 |
PAP
Persistent Asset Partners
Hong Kong
|
-$69.7K |